75
Participants
Start Date
July 31, 2002
Primary Completion Date
July 31, 2005
Study Completion Date
July 31, 2005
Malaria ICC-1132
ICC-1132, a candidate malaria vaccine, with alhydrogel will be in 2 ml glass vials containing ICC-1132 at either 40 mcg/ml or 100 mcg/ml concentration formulated with alhydrogel at 1mg/ml. Each vial will contain approximately 0.8 ml solution to permit recovery of 0.5 ml for injection. When shaken, the solution is off-white to greyish-white turbid liquid free of foreign particulate matter.
Alhydrogel
Aluminum hydroxide gel.
University of Maryland Baltimore, Baltimore
National Institute of Allergy and Infectious Diseases (NIAID)
NIH